Your browser doesn't support javascript.
loading
Selective inhibition of the BD2 bromodomain of BET proteins in prostate cancer.
Faivre, Emily J; McDaniel, Keith F; Albert, Daniel H; Mantena, Srinivasa R; Plotnik, Joshua P; Wilcox, Denise; Zhang, Lu; Bui, Mai H; Sheppard, George S; Wang, Le; Sehgal, Vasudha; Lin, Xiaoyu; Huang, Xiaoli; Lu, Xin; Uziel, Tamar; Hessler, Paul; Lam, Lloyd T; Bellin, Richard J; Mehta, Gaurav; Fidanze, Steve; Pratt, John K; Liu, Dachun; Hasvold, Lisa A; Sun, Chaohong; Panchal, Sanjay C; Nicolette, John J; Fossey, Stacey L; Park, Chang H; Longenecker, Kenton; Bigelow, Lance; Torrent, Maricel; Rosenberg, Saul H; Kati, Warren M; Shen, Yu.
Affiliation
  • Faivre EJ; Oncology Discovery, AbbVie, North Chicago, IL, USA.
  • McDaniel KF; Oncology Discovery, AbbVie, North Chicago, IL, USA.
  • Albert DH; Oncology Discovery, AbbVie, North Chicago, IL, USA.
  • Mantena SR; Preclinical Safety, Development Sciences, AbbVie, North Chicago, IL, USA.
  • Plotnik JP; Oncology Discovery, AbbVie, North Chicago, IL, USA.
  • Wilcox D; Oncology Discovery, AbbVie, North Chicago, IL, USA.
  • Zhang L; Oncology Discovery, AbbVie, North Chicago, IL, USA.
  • Bui MH; Oncology Discovery, AbbVie, North Chicago, IL, USA.
  • Sheppard GS; Oncology Discovery, AbbVie, North Chicago, IL, USA.
  • Wang L; Oncology Discovery, AbbVie, North Chicago, IL, USA.
  • Sehgal V; Oncology Discovery, AbbVie, North Chicago, IL, USA.
  • Lin X; Oncology Discovery, AbbVie, North Chicago, IL, USA.
  • Huang X; Oncology Discovery, AbbVie, North Chicago, IL, USA.
  • Lu X; Oncology Discovery, AbbVie, North Chicago, IL, USA.
  • Uziel T; Oncology Discovery, AbbVie, North Chicago, IL, USA.
  • Hessler P; Oncology Discovery, AbbVie, North Chicago, IL, USA.
  • Lam LT; Oncology Discovery, AbbVie, North Chicago, IL, USA.
  • Bellin RJ; Oncology Discovery, AbbVie, North Chicago, IL, USA.
  • Mehta G; Oncology Discovery, AbbVie, North Chicago, IL, USA.
  • Fidanze S; Oncology Discovery, AbbVie, North Chicago, IL, USA.
  • Pratt JK; Oncology Discovery, AbbVie, North Chicago, IL, USA.
  • Liu D; Oncology Discovery, AbbVie, North Chicago, IL, USA.
  • Hasvold LA; Oncology Discovery, AbbVie, North Chicago, IL, USA.
  • Sun C; Oncology Discovery, AbbVie, North Chicago, IL, USA.
  • Panchal SC; Oncology Discovery, AbbVie, North Chicago, IL, USA.
  • Nicolette JJ; Preclinical Safety, Development Sciences, AbbVie, North Chicago, IL, USA.
  • Fossey SL; Preclinical Safety, Development Sciences, AbbVie, North Chicago, IL, USA.
  • Park CH; Oncology Discovery, AbbVie, North Chicago, IL, USA.
  • Longenecker K; Oncology Discovery, AbbVie, North Chicago, IL, USA.
  • Bigelow L; Oncology Discovery, AbbVie, North Chicago, IL, USA.
  • Torrent M; Oncology Discovery, AbbVie, North Chicago, IL, USA.
  • Rosenberg SH; Oncology Discovery, AbbVie, North Chicago, IL, USA.
  • Kati WM; Oncology Discovery, AbbVie, North Chicago, IL, USA.
  • Shen Y; Oncology Discovery, AbbVie, North Chicago, IL, USA. yu.shen@abbvie.com.
Nature ; 578(7794): 306-310, 2020 02.
Article in En | MEDLINE | ID: mdl-31969702
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Pyridines / Pyrroles / Transcription Factors / Cell Cycle Proteins / Protein Domains Type of study: Prognostic_studies Limits: Animals / Humans / Male Language: En Journal: Nature Year: 2020 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Pyridines / Pyrroles / Transcription Factors / Cell Cycle Proteins / Protein Domains Type of study: Prognostic_studies Limits: Animals / Humans / Male Language: En Journal: Nature Year: 2020 Document type: Article Affiliation country: Country of publication: